We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Some pharmaceutical firms in 2002 overcharged public-health facilities participating in a federal drug-discount program by tens of millions of dollars, according to a follow-up study by HHS’ Office of Inspector General (OIG).